Centre Antoine Lacassagne Clinical Trials
Sponsors / Centre Antoine Lacassagne
ClinicalTrials.gov lists 64 trials for which Centre Antoine Lacassagne is named as lead sponsor. Of these, 13 are recruiting, 2 are active without new recruitment, and 37 have completed. The registry records 6 terminated or withdrawn trials for Centre Antoine Lacassagne. The most common reasons cited for termination include slow or insufficient recruitment. Planned participant enrollment across these trials sums to 49,778. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
64
Total Trials
13
Recruiting
2
Other Active
37
Completed
6
Terminated / Withdrawn
49,778
Total Enrollment
Termination reasons: Other83% · Recruitment17%
Recent Terminations
- Melanoma"insufficient quality of data collection"
- Prostatic Neoplasm"Feasibility issues"
- Glioblastoma"changing the standard of care"
- Endometrial Cancer"Enrollment difficulties"
- Breast Cancer"Low rythm of inclusions"
- Malignant Mast Cell Tumors
Active Trials (2 total)
- NCT05931302
- Localized Breast Cancer PHASE2NCT04680715
- NCT07377084
- Small Cell Lung Cancer PHASE1NCT03467360
- NCT06627738
- NCT06400849
- NCT06782451
- NCT04198727
- Glioblastoma Multiforme PHASE1/PHASE2NCT02331498
- NCT04934293
- NCT06606366
- NCT06833229
- Cancer NANCT06851975
- Radiosurgery PHASE2NCT03548428
- NCT06029218